Florian Beigel

LMU Klinikum — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index4.3kcitations126works16.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(50), Microscopic Colitis(28), Cytokine Signaling Pathways and Interactions(14), Immunodeficiency and Autoimmune Disorders(14), IL-33, ST2, and ILC Pathways(13)

Publications126 total

CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites
Scientific Reports·2025Open Access
Autoantibody Profiling in Ulcerative Colitis: Identification of Early Immune Signatures and Disease-Associated Antigens for Improved Diagnosis and Monitoring
International Journal of Molecular Sciences·2025Open Access
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice—An unbiased functional study
Proceedings of the National Academy of Sciences·2025· 18 citedOpen Access
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins
Cell·2024· 62 citedOpen Access
Su1733 ORAL IL-23R ANTAGONIST MINIPROTEIN MB1 IS AS EFFECTIVE AS GUSELKUMAB IN A PRECLINICAL MODEL OF COLITIS
Gastroenterology·2024
Humanized NSG Mouse Models as a Preclinical Tool for Translational Research in Inflammatory Bowel Diseases
International Journal of Molecular Sciences·2023· 5 citedOpen Access
Vitamin D supprimiert die intestinale und systemische Expression des bei Patienten mit chronisch entzündlichen Darmerkrankungen systemisch erhöhten Th17-Chemokins CCL20
Zeitschrift für Gastroenterologie·2023
It is not NOD2 — genetic and clinical risk factors for postoperative complications following ileocolic resection in Crohn’s disease
International Journal of Colorectal Disease·2022· 6 citedOpen Access
Genetische und klinische Risikofaktoren für postoperative Komplikationen nach Ileozökalresektion bei Morbus Crohn
Zeitschrift für Gastroenterologie·2022
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression
Clinical and Translational Gastroenterology·2022· 13 citedOpen Access
NOD/scid IL‐2Rγ<sup>null</sup> mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
Immunity Inflammation and Disease·2021· 9 citedOpen Access
The PI3K pathway as a therapeutic intervention point in inflammatory bowel disease
Immunity Inflammation and Disease·2021· 29 citedOpen Access
Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis
Journal of Crohn s and Colitis·2021· 16 citedOpen Access
Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells
Disease Models & Mechanisms·2020· 14 citedOpen Access
Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery
PLoS ONE·2020· 9 citedOpen Access
Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis
PLoS ONE·2020· 25 citedOpen Access
DOP33 Stratification of patients for treatment with adalimumab by a combination of immune-profiling and in vivo efficacy studies in a novel mouse model of ulcerative colitis
Journal of Crohn s and Colitis·2020Open Access
DOP52 The phenotype of NOD-scid IL-2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn’s disease or ulcerative colitis reflects the respective disease
Journal of Crohn s and Colitis·2020
The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab
Inflammatory Bowel Diseases·2019· 14 citedOpen Access
10. S,M,L,XL &amp; “GENERIC CITY” (1994–1998): NO END TO REVISION
2019
page 1 of 7Next →

Frequent Co-authors

Stephan Brand(35), Burkhard Göke(31), Thomas Ochsenkühn(19), Julia Seiderer(17), Torsten Olszak(16), Cornelia Tillack(15), Jürgen Glas(14), Julia Diegelmann(14), Matthias Friedrich(11), Fabian Schnitzler(10), Julia Dambacher(9), Johannes Stallhofer(9), Martin Wetzke(9), Matthias Siebeck(9), Roswitha Gropp(9), Christoph J. Auernhammer(8), Maria Weidinger(8), Peter Lohse(8), Helmut M. Diepolder(7), Rüdiger P. Laubender(7)